Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Cell
|
September 4, 2010
Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma
Mark P Chao, Ash A Alizadeh, Chad Tang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2019
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia
Noelle V Frey, Pamela A Shaw, Elizabeth O Hexner, et al.
Blood Advances
|
January 31, 2025
Evolving racial/ethnic disparities in AML survival in the novel therapy era
Xin Wang, Phyllis A Gimotty, Andrew H Matthews, et al.
The Journal of Clinical Investigation
|
August 30, 2016
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
Marco Ruella, David M Barrett, Saad S Kenderian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 26, 2021
Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques
Aisha A AlJanahi, Cicera R Lazzarotto, Shirley Chen, et al.
Cancer Discovery
|
February 1, 2020
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
Nathan Singh, Yong Gu Lee, Olga Shestova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19
Caroline Diorio, Rawan Shraim, Regina Myers, et al.
Cell
|
June 2, 2018
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
Miriam Y Kim, Kyung-Rok Yu, Saad S Kenderian, et al.
Nature Communications
|
March 20, 2025
Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models
Stefano Pierini, Rashid Gabbasov, Maria Cecilia Oliveira-Nunes, et al.
Nature Medicine
|
February 7, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
Kim A Reiss, Mathew G Angelos, E Claire Dees, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Cell
|
September 4, 2010
Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma
Mark P Chao, Ash A Alizadeh, Chad Tang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2019
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia
Noelle V Frey, Pamela A Shaw, Elizabeth O Hexner, et al.
Blood Advances
|
January 31, 2025
Evolving racial/ethnic disparities in AML survival in the novel therapy era
Xin Wang, Phyllis A Gimotty, Andrew H Matthews, et al.
The Journal of Clinical Investigation
|
August 30, 2016
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
Marco Ruella, David M Barrett, Saad S Kenderian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 26, 2021
Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques
Aisha A AlJanahi, Cicera R Lazzarotto, Shirley Chen, et al.
Cancer Discovery
|
February 1, 2020
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
Nathan Singh, Yong Gu Lee, Olga Shestova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19
Caroline Diorio, Rawan Shraim, Regina Myers, et al.
Cell
|
June 2, 2018
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
Miriam Y Kim, Kyung-Rok Yu, Saad S Kenderian, et al.
Nature Communications
|
March 20, 2025
Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models
Stefano Pierini, Rashid Gabbasov, Maria Cecilia Oliveira-Nunes, et al.
Nature Medicine
|
February 7, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
Kim A Reiss, Mathew G Angelos, E Claire Dees, et al.
Page
of 10